New blood gas device put to the test – but trial halted early
NCT ID NCT02801162
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared a new device, the Proxima 3®, to standard hospital equipment for measuring blood gases like oxygen and carbon dioxide. Researchers wanted to see if the new device was accurate and fast in patients whose condition was changing quickly. The trial was stopped early after enrolling only 20 adults with arterial lines, so the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Proxima 3® arterial blood gas analysis system
What this could lead to
If successful, this could provide a faster, reliable way to measure blood gases in rapidly changing clinical situations.
What could go wrong
The trial was terminated early with only 20 participants, so results are limited and may not be conclusive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitair Ziekenhuis Brussel
Jette, Vlaams-Brabant, 1090, Belgium